false0001567892 0001567892 2019-09-06 2019-09-06
申博代理官网登入




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): September 6, 2019
 
Mallinckrodt plc

(Exact name of registrant as specified in its charter)

Ireland
001-35803
98-1088325
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

3 Lotus Park, The Causeway, Staines-Upon-Thames
Surrey TW18 3AG, United Kingdom
(Address of principal executive offices) (Zip Code)
 
Registrant's telephone number, including area code:  +44 017 8463 6700
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Ordinary shares, par value $0.20 per share
MNK
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  




申博代理官网登入


Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.

On August 7, 2019, Mallinckrodt plc announced that it was not proceeding with a planned spin-off of its Specialty Generics business. Given that the spin-off plans have been suspended, Matthew Harbaugh, Executive Vice President and President, Specialty Generics, left the company effective September 6, 2019.



申博代理官网登入


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
 
 
MALLINCKRODT PLC
 
 
 
 
(registrant)
 
 
 
 
 
Date:
September 9, 2019
 
By:
/s/ Mark J. Casey
 
 
 
 
Mark J. Casey
 
 
 
 
General Counsel



www.55sbc.com 百家乐登入 菲律宾申博游戏登入 申博直营网 申博支付宝怎么充值 申博娱乐
菲律宾申博管理网登入 菲律宾申博娱乐城官网 菲律宾太阳娱乐网138登入 申博支付宝怎么充值 申博代理开户登入 申博注册登入
申博支付宝充值 菲律宾太阳城开户登入 申博在线开户登入 菲律宾申博真人娱乐登入 菲律宾申博代理开户合作 www.sbc188.com